Author:
Cesaro Simone,Caddeo Giulia
Abstract
AbstractThe central venous catheter (CVC) is a key tool for patients undergoing hematopoietic cell transplantation. CVC ensures a stable, adequate, and safe venous access. The use of a CVC requires an adequate knowledge and training by health personnel to maintain its functionality and to prevent complications (malfunctioning, partial or complete occlusion, dislodgement, kinking, rupture, thrombosis, and catheter-related bloodstream infections) that can cause the premature removal of CVC or be life-threatening. The choice of CVC must consider the characteristics of the patient, the treatment plan, and the performance expected by the device.
Publisher
Springer International Publishing
Reference14 articles.
1. Blanco-Guzman MO. Implanted vascular access device options: a focus review on safety and outcomes. Transfusion. 2018;58:558–68.
2. van den Bosch CH, van Woensel J, van de Wetering MD. Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer. Cochrane Database Syst Rev. 2021;10:CD003295.
3. Cellini M, Bergadano A, Crocoli A, Badino C, Carraro F, Sidro L, Botta D, Pancaldi A, Rossetti F, Pitta F, Cesaro S. Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease. J Vasc Access. 2022;23:3–17.
4. Cesaro S, Tridello G, Cavaliere M, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol. 2009;27:2059–65.
5. Cesaro S, Cavaliere M, Pegoraro A, et al. A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients. Ann Hematol. 2016;95:817–25.